Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Neurobiol Dis. 2015 Dec 29;87:124–133. doi: 10.1016/j.nbd.2015.12.015

Figure 6.

Figure 6

Western blot was conducted for time-course studies of (A) PPARΥ and (B) CD36 at 0, 3, 6, 12 hours, 1, 3, 5, 7 days after GMH. Western blot was then conducted at 72 hours for (C) PPAR-Υ and (D) CD36. Values are expressed as mean±SD. *P<0.05 compared with sham, #P<0.05 compared with vehicle, and P<0.05 compared with inhibitor and agonist. N=6 per group; and h and d, hour(s) and day(s).